These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32208815)

  • 1. Correlation of pre-exposure prophylaxis adherence to a mental health diagnosis or experience of childhood trauma in high-risk youth.
    Young LB; Lalley-Chareczko L; Clark D; Ramos MT; Nahan RA; Troutman GS; Cantor R; DiFlavis L; Koenig HC
    Int J STD AIDS; 2020 Apr; 31(5):440-446. PubMed ID: 32208815
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP".
    Mayer KH; Safren SA; Elsesser SA; Psaros C; Tinsley JP; Marzinke M; Clarke W; Hendrix C; Wade Taylor S; Haberer J; Mimiaga MJ
    AIDS Behav; 2017 May; 21(5):1350-1360. PubMed ID: 27848089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on Pre-Exposure Prophylaxis Regimens among Men Who Have Sex with Men: A Prospective Cohort Study.
    Wu D; Tao H; Dai J; Liang H; Huang A; Zhong X
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31818006
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenges to PrEP use and perceptions of urine tenofovir adherence monitoring reported by individuals on PrEP.
    Hunt T; Lalley-Chareczko L; Daughtridge G; Swyryn M; Koenig H
    AIDS Care; 2019 Oct; 31(10):1203-1206. PubMed ID: 30821473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaching High-Risk Patients for HIV Preexposure Prophylaxis.
    Riddell J; Cohn JA
    JAMA; 2016 Jul; 316(2):211-2. PubMed ID: 27404188
    [No Abstract]   [Full Text] [Related]  

  • 6. Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China.
    Hu Y; Zhong XN; Peng B; Zhang Y; Liang H; Dai JH; Zhang JY; Huang AL
    BMC Infect Dis; 2018 Nov; 18(1):575. PubMed ID: 30442106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Adherence to HIV Pre-Exposure Prophylaxis among Veterans.
    Huang M; Liu W; Plomondon ME; Prochazka AV; Bessesen MT
    J Gen Intern Med; 2018 Mar; 33(3):253-255. PubMed ID: 29302884
    [No Abstract]   [Full Text] [Related]  

  • 8. Murnane, Coley, and Baeten respond to "every good randomization deserves observation".
    Murnane PM; Coley RY; Baeten JM
    Am J Epidemiol; 2015 Nov; 182(10):861-2. PubMed ID: 26487341
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.
    Mugo PM; Sanders EJ; Mutua G; van der Elst E; Anzala O; Barin B; Bangsberg DR; Priddy FH; Haberer JE
    AIDS Behav; 2015 May; 19(5):794-801. PubMed ID: 25432877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with high rates of antiretroviral medication adherence among youth living with perinatal HIV in Thailand.
    Kang E; Delzell DA; Chhabra M; Oberdorfer P
    Int J STD AIDS; 2015 Jul; 26(8):534-41. PubMed ID: 25080289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
    Sheth AN; Momplaisir F; Dumond JB
    JAMA; 2024 Mar; 331(11):912-914. PubMed ID: 38427361
    [No Abstract]   [Full Text] [Related]  

  • 13. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
    Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical students reflect on the future of Pre-Exposure Prophylaxis use among adolescents and young adults.
    Eweka I; Fleuriscar J; Fleuriscar J; Adeyemi-Jones A; Dillon B; Albritton T
    Prev Med; 2018 Aug; 113():122-123. PubMed ID: 29792894
    [No Abstract]   [Full Text] [Related]  

  • 15. Audit of patient retention in pre-exposure prophylaxis (PrEP) services in an integrated sexual reproductive health service setting.
    Cochrane E; Knapper C
    Int J STD AIDS; 2019 Dec; 30(14):1432-1435. PubMed ID: 31795927
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic-Based Methods of Adherence Assessment in HIV Prevention.
    Brooks KM; Anderson PL
    Clin Pharmacol Ther; 2018 Dec; 104(6):1056-1059. PubMed ID: 30178462
    [No Abstract]   [Full Text] [Related]  

  • 18. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of medication therapy management in preexposure prophylaxis therapy for HIV prevention.
    Ferrell KW; Woodard LM; Woodard TJ
    J Pharm Pract; 2015 Feb; 28(1):10-2. PubMed ID: 25500557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental health disorders and substance use among people living with HIV in Nepal: their influence on non-adherence to anti-retroviral therapy.
    Pokhrel KN; Pokhrel KG; Sharma VD; Poudel KC; Neupane SR; Mlunde LB; Jimba M
    AIDS Care; 2019 Aug; 31(8):923-931. PubMed ID: 30835503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.